Friday, January 9, 2009
pehel.com
Home Latest News Pakistan World Science / Technology Sports Entertainment Health Business


FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A
Source: Medical News Today E-Mail this News Story to a friend E-Mail this Story
Category: Health
Publication Date: Mon, 13 Oct 2008 05:00:00 PDT
News URL: http://www.medicalnewstoday.com/articles/125283.php
FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia AThe U.S. Food and Drug Administration has approved a new use for the blood product Kogenate FS to reduce the frequency of bleeding episodes and prevent joint damage in children with the most severe form of hemophilia. Hemophilia A is a rare, hereditary, bleeding disorder in which a protein needed to form blood clots, factor VIII, is missing or its level is reduced.
Click here for full Story
http://www.medicalnewstoday.com/articles/125283.php
Bookmark this news story online:
Add FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to BlinkListAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to DeliciousAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to DiggAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to FarkAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to FurlAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to BlogarithmAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to MeneameAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to My Yahoo!Add FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to ReddItAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to ShadowsAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to SimpyAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to SpurlAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to Sync2ItAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to MagnoliaAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to NewsVineAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to Ask Jeeves
Add FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to Raw SugarAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to DiigoAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to NetVouzAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to Stumble UponAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to SegnaloAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to Google BookmarksAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to Microsoft LiveAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to BlogMarksAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to WinkAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to TechnoratiAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to Feed Me LinksAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to LinkaGoGoAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to BlueDotAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to Mister WongAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to TailRankAdd FDA Licenses Drug To Prevent Joint Damage In Children With Hemophilia A to Yahoo Bookmarks

Comments

No comments found... be the first one to comment on this story :)

Post a Comment
Name:
   
E-Mail Address:
   
Website / Blog URL (optional):
   
Comments:
   
Security Code:
   
  
   By submitting these comments, you are agreeing to our Terms of Service
    
Latest News
Latest News World News Pakistan News Technology News Entertainment News Business News Sports News
bullet Perfectionist Protein-Maker Trashes Errors
bullet Unibioscreen Announces Progress Of Phase I Clinical Trial For UNBS1450 In Europe In Cancer Patients With Advanced Solid Tumors
bullet Excessive Use Of Antiviral Drugs Could Aid Deadly Flu According To Study
bullet Don't Let 'iPatient' Detract From Hands-On Medicine, Stanford Author/Educator Urges
bullet Absence Of CLP Protein Can Be Indicative Of Oral Cancer
bullet U.S. Patent And Trademark Office Accepts Pfizer's Reissue Application On Lipitor Enantiomer Patent
bullet Target Discovered That Could Ease Spinal Muscular Atrophy Symptoms
bullet BASi Receives A European Patent For Culex(R)
bullet Winter Babies Face Socioeconomic Disadvantages
bullet Xenomics, Inc. Discusses HPV Screening Test Based On Transrenal DNA Technology At 52nd All India Congress Of Obstetrics & Gynecology
bullet Court Rules In Favor Of Medtronic In Fidelis Litigation
bullet Human Genomics In China
bullet The MDS Foundation Says VIDAZA Approval In Europe Could Provide Survival Benefits To Patients With Myelodysplastic Syndromes And Related Cancers
bullet Initial Findings Could Lead To A New Approach For Treating Fragile X Syndrome
bullet Advaxis' Phase II Clinical Trial "HOLD" Lifted
bullet Women's Access To Donated Kidneys Declines With Age, Particularly Compared With Men
bullet Cameron Health Commences Clinical Trial Of The Minimally Invasive Totally Subcutaneous Implantable Defibrillator For Treatment Of SCA
bullet Avian Flu Becoming More Resistant To Antiviral Drugs, Says University Of Colorado Study
bullet New Test Will Catch Sports Cheats On New Endurance Drugs
bullet Mountaineers Measure Lowest Human Blood Oxygen Levels On Record
bullet HHS Issues Action Plan To Prevent Health Care-Associated Infections
bullet Health Care Delivery Could Be Adversely Affected By Cost Containment Focus
bullet QuantRx(R) Announces FDA 510(k) Clearance For Its RapidSense(R) Methamphetamine Test
bullet HWI Scientist First In World To Unravel Structure Of Key Breast Cancer Target Enzyme
bullet KineMed Awarded Michael J. Fox Foundation Funding To Validate Translational Biomarker Of Microtubule Function In Parkinson's Disease
 
© 2007 Verge Systems